Multiplex Assay Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array)

CHR-NA1; N-AChRA1; NAChRA1; ACHRA; ACHRD; CMS2A; FCCMS; SCCMS; Acetylcholine receptor subunit alpha; N-AChR-A1; Neuronal Acetylcholine Receptor Alpha 1,Muscle

Specificity

This assay has high sensitivity and excellent specificity for detection of Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-90 84
EDTA plasma(n=5) 85-105 97
heparin plasma(n=5) 79-88 83

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 90-101% 93-104% 89-101% 82-102%
EDTA plasma(n=5) 80-92% 93-105% 94-102% 87-97%
heparin plasma(n=5) 88-96% 98-105% 91-101% 98-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Journal of Peptides Effects of Endurance and Resistance Training on Calcitonin Gene-Related Peptide and Acetylcholine Receptor at Slow and Fast Twitch Skeletal Muscles and Sciatic Nerve in Male Wistar Rats PubMed: PMC3382945
Progress in Neuro-Psychopharmacology & Biological Psychiatry Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats pubmed:29269186
Saudi Pharmaceutical Journal Sukkari dates seed improves type-2 diabetes mellitus-induced memory impairment by reducing blood glucose levels and enhancing brain cholinergic … Pubmed:35812141
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA981Hu01 Recombinant Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA981Hu01 Polyclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) WB
MAA981Hu21 Monoclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) WB; IHC; ICC; IP.
SEA981Hu ELISA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA981Hu CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) Chemiluminescent immunoassay for Antigen Detection.
LMA981Hu Multiplex Assay Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMA981Hu Multiplex Assay Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.